Seo Seung-Hwan, Ham Do-Won, Lee Ji-Eun, Jong Seung-Min, Kim Sang-Kyu, Lee Seung-Ho, Yu Hye-Young, Shin Eun-Hee
Institute of Endemic Diseases, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
Department of Tropical Medicine and Parasitology, Seoul National University College of Medicine, Seoul, Republic of Korea.
J Ginseng Res. 2025 May;49(3):271-281. doi: 10.1016/j.jgr.2025.01.006. Epub 2025 Jan 30.
Obesity is an important risk factor of intestinal inflammatory disease. This study aimed to evaluate the effects of Red ginseng extract powder (RGEP) and Red ginseng dietary fiber (RGDF) on the maintenance of immune and functional homeostasis in recovering obesity-induced impairment of intestinal immunity.
Diet-induced obesity in C57BL/6 male mice was achieved by feeding them a 60 % high-fat diet for six weeks. The diet-induced obese (DIO) mice were administered RGEP (205, 410, or 820 mg/kg), fructooligosaccharide (FOS, 820 mg/kg), or RGDF (410, 820, or 1640 mg/kg) once daily for 4-8 weeks. The effects of RGEP or RGDF administration were evaluated via stool trait and gastrointestinal (GI) motility, inflammatory biomarkers and cytokines in mesenteric lymph nodes and intestine, mucosal protective genes, bacterial toxicity, and histopathological features of the intestines.
RGEP or RGDF administration to the DIO mice reduced mucosal barrier damaging factor (α1-antitrypsin), inflammatory cytokine levels, factors related to inflammatory responses (C-reactive protein (CRP), iNOS, NF-κB, MPO, and Calprotectin), and levels of urinary indican and intestinal β-glucuronidase. Conversely, RGEP or RGDF administration increased intestinal motility, levels of short-chain fatty acids (SCFAs) and β-defensin-2, and mucus barrier functional factor (MUC2) expression. Histopathological features of the small intestine recovered to normal levels after RGEP or RGDF administration.
Our results demonstrated that RGEP and RGDF were effective for maintaining intestinal immune and functional homeostasis by recovering impaired immune and barrier function in DIO mice.
肥胖是肠道炎症性疾病的重要危险因素。本研究旨在评估红参提取物粉末(RGEP)和红参膳食纤维(RGDF)对恢复肥胖引起的肠道免疫损伤后维持免疫和功能稳态的影响。
通过给C57BL/6雄性小鼠喂食60%的高脂饮食六周来诱导饮食性肥胖。给饮食诱导肥胖(DIO)小鼠每日一次给予RGEP(205、410或820毫克/千克)、低聚果糖(FOS,820毫克/千克)或RGDF(410、820或1640毫克/千克),持续4 - 8周。通过粪便性状和胃肠(GI)蠕动、肠系膜淋巴结和肠道中的炎症生物标志物和细胞因子、黏膜保护基因、细菌毒性以及肠道的组织病理学特征来评估RGEP或RGDF给药的效果。
给DIO小鼠给予RGEP或RGDF可降低黏膜屏障破坏因子(α1 - 抗胰蛋白酶)、炎症细胞因子水平、与炎症反应相关的因子(C反应蛋白(CRP)、诱导型一氧化氮合酶(iNOS)、核因子κB(NF - κB)、髓过氧化物酶(MPO)和钙卫蛋白)以及尿靛基质和肠道β - 葡萄糖醛酸酶的水平。相反,给予RGEP或RGDF可增加肠道蠕动、短链脂肪酸(SCFAs)水平和β - 防御素 - 2以及黏液屏障功能因子(MUC2)的表达。给予RGEP或RGDF后小肠的组织病理学特征恢复到正常水平。
我们的结果表明,RGEP和RGDF通过恢复DIO小鼠受损的免疫和屏障功能,对维持肠道免疫和功能稳态有效。